Previous close | 18.17 |
Open | 18.17 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 18.17 - 18.17 |
52-week range | 16.66 - 25.36 |
Volume | |
Avg. volume | 136 |
Market cap | 8.813B |
Beta (5Y monthly) | 0.27 |
PE ratio (TTM) | 10.50 |
EPS (TTM) | 1.73 |
Earnings date | N/A |
Forward dividend & yield | 0.59 (3.26%) |
Ex-dividend date | 28 Mar 2024 |
1y target est | N/A |
Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; "Ono") today announced that in order to accelerate the open innovation, it has increased its investment pool from US$100 million to US$200 million to continue strategic investment in Ono Venture Investment Fund I, L.P. ("OVI FI"), which was established as a corporate venture capital fund in CA, USA in May 2020.
Ono Pharmaceutical Co. (OPHLF) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
OPHLF, TOELY and TLYS have been added to the Zacks Rank #5 (Strong Sell) List on June 2, 2023.